CAR T Cell Therapy in B-Cell Acute Lymphoblastic Leukaemia: Insights From Mathematical Models

doi 10.1101/2020.03.18.20038257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Molecular Processes Involved in B Cell Acute Lymphoblastic Leukaemia

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2017English

CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Immunotherapy
OncologyAllergyImmunology
2017English

Corrigendum: Signalling Thresholds and Negative B-Cell Selection in Acute Lymphoblastic Leukaemia

Nature
Multidisciplinary
2016English

Aberrant Expression of a T-Cell and a Monocytic Antigen in a Newly Diagnosed Precursor B-Cell Acute Lymphoblastic Leukaemia

National Journal of Health Sciences
2017English

Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia

British Journal of Haematology
Hematology
2020English

Engineered T Cells Towards TNFRSF13C (BAFFR): A Novel Strategy to Efficiently Target B-Cell Acute Lymphoblastic Leukaemia

British Journal of Haematology
Hematology
2017English

CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy